Southwest Michigan First Release: PharmOptima And Kalesxyn Form Joint Service Alliance 
10/19/2005 5:13:16 PM

KALAMAZOO PharmOptima and Kalexsyn have formed a joint service alliance to offer a broad range of services for the drug discovery and research markets. Kalexsyn CEO David Zimmermann said the two companies will provide an integrated drug discovery service platform. This platform will provide an expedited drug discovery timeline for our client partners. Our medicinal chemistry skill, coupled with PharmOptima’s in vitro and in vivo capabilities creates a very experienced drug discovery team, Zimmermann said.